These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6346142)

  • 21. Cancer incidence and survival in kidney transplant patients.
    Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
    Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of noncutaneous malignancies in kidney transplant recipients: a 20-year follow-up.
    Mouquet C; Benalia H; Ourahma S; Barrou B; Bitker MO; Luciani J; Chatelain C; Viars P
    Transplant Proc; 1995 Apr; 27(2):1764. PubMed ID: 7725492
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimizing the risk of posttransplant malignancy.
    Campistol JM
    Transplantation; 2009 Apr; 87(8 Suppl):S19-22. PubMed ID: 19384182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
    Hiesse C; Larue JR; Kriaa F; Blanchet P; Bellamy J; Benoit G; Charpentier B
    Transplant Proc; 1995 Aug; 27(4):2450-1. PubMed ID: 7652877
    [No Abstract]   [Full Text] [Related]  

  • 26. Solitary fibrous tumor of the kidney: a case report.
    Makris A; Tabaza R; Brehmer B; Lindemann-Docter K; Wildberger J; Jakse G
    Can J Urol; 2009 Oct; 16(5):4854-6. PubMed ID: 19796466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period.
    Frei U; Bode U; Repp H; Schindler R; Brunkhorst R; Vogt P; Hauss J; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1394-6. PubMed ID: 8442152
    [No Abstract]   [Full Text] [Related]  

  • 28. Kidney transplantation and tumours.
    Forslund T; Kock B; Kuhlbäck B
    Ann Clin Res; 1980 Apr; 12(2):55-8. PubMed ID: 7004326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer following successful cadaveric donor renal transplantation.
    Sheil AG; Mahony JF; Horvath JS; Johnson JR; Tiller DJ; Stewart JH; May J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):733-5. PubMed ID: 7022942
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tumors and kidney transplantation].
    Brünisholz M; Hodel K; Brunner FP; Harder F; Torhorst J; Thiel G
    Schweiz Med Wochenschr; 1984 Dec; 114(51):1915-24. PubMed ID: 6395328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does growth hormone treatment affect the risk of post-transplant renal cancer?
    Mehls O; Wilton P; Lilien M; Berg U; Broyer M; Rizzoni G; Waldherr R; Opelz G
    Pediatr Nephrol; 2002 Dec; 17(12):984-9. PubMed ID: 12520324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy under immunosuppressive therapy including cyclosporine.
    Ritters B; Grabensee B; Heering P
    Transplant Proc; 1994 Oct; 26(5):2656-7. PubMed ID: 7940831
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
    Reddy KS; Stablein D; Taranto S; Stratta RJ; Johnston TD; Waid TH; McKeown JW; Lucas BA; Ranjan D
    Am J Kidney Dis; 2003 Feb; 41(2):464-70. PubMed ID: 12552511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer after kidney transplantation].
    Sandrini S; Setti G; Bossini N; Maiorca P
    G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant neoplasms arising "de novo" after a kidney transplant. Our experience and a review of the literature].
    Tommasi GV; Arcuri V; Fontana I; Barabino M; Vassallo S; Casolino V; Valente U
    G Chir; 1994; 15(1-2):11-4. PubMed ID: 8018469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo cancer in transplant recipients.
    Kim MS; Kim SI; Kim YS; Oh CK; Park K
    Transplant Proc; 1996 Jun; 28(3):1651-2. PubMed ID: 8658822
    [No Abstract]   [Full Text] [Related]  

  • 38. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.
    Sheil AG; Disney AP; Mathew TH; Amiss N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1383-4. PubMed ID: 8442150
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neoplasm prevalence in renal transplantation].
    Gómez dos Santos V; Burgos Revilla FJ; Pascual Santos J; Orofino Ascunce L; Fernández-Juárez G; Crespo Martínez L; Clemente Ramos L; Carrera Puerta C; Marcen Letosa R; Escudero Barrilero A; Ortuño Mirete J
    Arch Esp Urol; 1997 Apr; 50(3):267-73; discussion 273-4. PubMed ID: 9265450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of cancer in renal allograft recipients.
    Yokota K; Fukumitsu M; Kuzuhara K; Otsubo O; Tomikawa S; Nagao T; Uchida H; Sato K; Nakayama Y; Endo T
    Transplant Proc; 1994 Aug; 26(4):1977-8. PubMed ID: 8066639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.